Article: Asthma alliance.(Schering-Plough, Texas Biotechnology)(Brief Article)

Article: ASTHMA ALLIANCE OF INDIANAPOLIS; Working to Educate ...
Indianapolis Recorder;  April 23, 2004 ;     545 words ... ... 23-2004 In January 1997, the Asthma Alliance of Indianapolis was formed as an asthma ... drastically increase. According to the Asthma Alliance of Indianapolis, a 1995 survey indicated ... Marion County Health Department and the Asthma Alliance of Indianapolis offer free education ...

Article: Asthma Alliance of Indianapolis increases awareness ...
Indianapolis Recorder;  May 20, 2005 ;     620 words ... ... their depiction of asthma during the Asthma Alliance of Indianapolis' annual Asthma Poster ... billboard in the Southport area. The Asthma Alliance sponsors the asthma poster contest ... these triggers from the home. The Asthma Alliance of Indianapolis began as an asthma ...

Article: Genome Therapeutics Announces Milestone in Asthma ...
PR Newswire;  June 4, 1998 ;     700+ words ... ... by Schering-Plough to develop new pharmaceuticals for asthma. "This is another important achievement this year in our asthma alliance with Schering-Plough, a leader in discovering and developing treatments for respiratory disorders," said Robert J ...

Article: Sequana and Boehringer Ingelheim expand asthma ...
Business Wire;  May 8, 1997 ;     700+ words ...LA JOLLA, CalifBW HealthWireMay 8, 1997--Sequana Therapeutics Inc. (NASDAQ:SQNA) Thursday announced an expansion of its strategic alliance with Boehringer Ingelheim in the area of asthma. Rapid progress, coupled with recent discoveries by Sequana's scientific team, led Boehringer Ingelheim to

Article: GSK and Galapagos form asthma ...
Pharma Marketletter;  January 17, 2005 ;     700+ words ...Belgium-headquartered genomics-based drug discovery company Galapagos and UK pharmaceutical major GlaxoSmithKline have entered into a target licensing and multi-year target identification collaboration in the area of respiratory and inflammatory diseases. Under the terms of the agreement, GSK gains

Article: Genome Therapeutics Announces Genetic Analysis Milestone in ...
PR Newswire;  February 2, 1999 ;     700+ words ...WALTHAM, Mass., Feb. 2 /PRNewswire/ -- Genome Therapeutics Corp. (Nasdaq: GENE) today announced that the Company has attained a research milestone in its human genomics alliance with Schering-Plough Corporation (NYSE: SGP) to discover new therapeutics for treating asthma. The research milestone

Article: Texas Biotechnology Acquires ICOS Corporation's ...
Business Wire;  April 23, 2003 ;     700+ words ... ... to Sitaxsentan and TBC3711 Returned to Texas Biotechnology Texas Biotechnology Corporation (Nasdaq:TXBI) and ICOS ... Nasdaq:ICOS) today announced that Texas Biotechnology has acquired ICOS' 50% interest in ICOS ...